United States · 
Who invested in EnPlusOne Biosciences?
EnPlusOne Biosciences's investors include Coatue and Northpond Ventures.
United States · Venture startup
Who invested in EnPlusOne Biosciences
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2025, from 1 source
- Latest round
- Venture, $10MFeb 2025
- Investors
- 2
The rounds
- Feb 2025
Founders and team
From EnPlusOne Biosciences's own website: 1 founder, 12 on the team.
Dan AhlstedtCo-founder, COO
- Bob FlynnDirector of Engineering
- Ella MeyerLead of RNA Synthesis
- Jeannine TongAssociate Scientist I
- Jenn DeFreitasAssociate Scientist I
- Jim WeissmanBoard Director
- Julia MooreBoard Director
- Jun YangSenior Scientist
- Lucas HoranManufacturing Associate II
- Sai NeelagiriResearch Associate
- Steven KasokBoard Chair
- Victoria DeMeoAssociate Scientist II
- Yuliya DantsuSenior Scientist
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about EnPlusOne Biosciences
How much has EnPlusOne Biosciences raised?
EnPlusOne Biosciences has raised $10M across 1 round since 2025.
When did EnPlusOne Biosciences last raise?
EnPlusOne Biosciences's most recent round was a Venture of $10M in Feb 2025.
What was EnPlusOne Biosciences's biggest round?
Its most recent round, $10M in Feb 2025, is also its largest on record.
Who backed EnPlusOne Biosciences first?
EnPlusOne Biosciences's first round on record, in Feb 2025, was backed by Coatue and Northpond Ventures.
What stage is EnPlusOne Biosciences at?
EnPlusOne Biosciences's latest named round is a Venture, in Feb 2025.
Where is EnPlusOne Biosciences based?
EnPlusOne Biosciences is based in the United States.
Companies like EnPlusOne Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.